Genmab A/S Stock

Genmab A/S R&D per Employee

The R&D Spending per Employee of Genmab A/S (GMAB.CO) as of Jul 26, 2026 is 2.66 M USD. In the previous year, R&D Spending per Employee was 2.35 M USD — a change of 13.07% (higher).

R&D per Employee

2.66 MUSD

YoY

13.07%

Last updated:

R&D Spending per Employee of Genmab A/S is 2026 2.66 M USD. R&D Spending per Employee of Genmab A/S was 2025 2.35 M USD. It decreases by 13.07% higher compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

R&D Spending per Employee of Genmab A/S is 2.66 M USD in 2026.

Access this data via the Eulerpool API

Workforce — Genmab A/S

All Key Metrics — Genmab A/S